Effects of candesartan on urinary alubumin and protein excretion in the diabetic patients with nephropathy

被引：0
|
作者：
Hayashi, I
Asakawa, H
Fukui, T
Tokunaga, K
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2112
引用
收藏
页码：A513 / A513
页数：1
相关论文
共 50 条
  • [21] Effects of pentoxifylline on the urinary protein excretion profile of type 2 diabetic patients with microproteinuria
    Rodriguez-Moran, M.
    Gonzalez-Gonzalez, G.
    Bermudez-Barba, M. V.
    de la Garza, C. E. Medina
    Tamez-Perez, H. E.
    Martinez-Martinez, F. J.
    Guerrero-Romero, F.
    CLINICAL NEPHROLOGY, 2006, 66 (01) : 3 - 10
  • [22] Mizoribine decreases urinary protein excretion in two patients with IgA nephropathy
    Yamabe, H
    Nakamura, N
    Nakamura, M
    Shimada, M
    Kumasaka, R
    Tsunoda, S
    CLINICAL NEPHROLOGY, 2005, 64 (01) : 79 - 80
  • [23] THE EFFECTS OF GLYCYRRHIZIN (GLY) ON BLOOD-PRESSURE AND URINARY ALBUMIN EXCRETION (UAE) IN PATIENTS WITH DIABETIC NEPHROPATHY (DN)
    OHISHI, A
    IIDA, T
    SARUTA, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 646 - 646
  • [24] The effects of dual blockade of the reninangiotensin system on urinary protein and transforming growth factor-β excretion in 2 groups of patients with IgA and diabetic nephropathy
    Song, JH
    Lee, SW
    Suh, JH
    Kim, ES
    Hong, SB
    Kim, KA
    Kim, MJ
    CLINICAL NEPHROLOGY, 2003, 60 (05) : 318 - 326
  • [25] Effects of the angiotensin II type 1 receptor antagonist candesartan, compared with angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathy
    Atsuhisa Sato
    Mitsuhisa Tabata
    Koichi Hayashi
    Takao Saruta
    Journal of Clinical and Experimental Nephrology, 2003, 7 (3): : 215 - 220
  • [26] URINARY EXCRETION OF PROFIBROTIC AND ANTIFIBROTIC GROWTH FACTORS IN TYPE I DIABETIC PATIENTS: THE RELATION WITH DIABETIC NEPHROPATHY
    Bondar, I. A.
    Klimontov, V. V.
    Parfentieva, E. M.
    Romanov, V. V.
    Nadeev, A. P.
    TERAPEVTICHESKII ARKHIV, 2012, 84 (06): : 36 - 40
  • [27] Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy
    Sato, H
    Iwano, M
    Akai, Y
    Kurioka, H
    Kubo, A
    Yamaguchi, T
    Hirata, E
    Kanauchi, M
    Dohi, K
    AMERICAN JOURNAL OF NEPHROLOGY, 1998, 18 (06) : 490 - 494
  • [28] Urinary Excretion of Kidney Aquaporins as Possible Biomarker of Diabetic Nephropathy
    Procino, Giuseppe
    Rossi, Luigi
    Nicoletti, Maria Celeste
    Carmosino, Monica
    Di Franco, Antonella
    Indrio, Francesca
    Lella, Rosa
    Laviola, Luigi
    Gesualdo, Loreto
    Svelto, Maria
    FASEB JOURNAL, 2016, 30
  • [29] LISINOPRIL, BUT NOT NIFEDIPINE, REDUCES URINARY ALBUMIN EXCRETION IN DIABETIC NEPHROPATHY
    HOLDAAS, H
    HARTMANN, A
    LIEN, MG
    NILSEN, L
    FAUCHALD, P
    JERVELL, J
    BERG, KJ
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 239 - 239
  • [30] Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy
    Jiang, Hongjuan
    Guan, Guangju
    Zhang, Rui
    Liu, Gang
    Liu, Haiying
    Hou, Xianghua
    Cheng, Jing
    NEPHROLOGY, 2009, 14 (03) : 332 - 337
12345